| Blockade of individual Notch ligands and receptors controls graft-versus-host disease IT Tran, AR Sandy, AJ Carulli, C Ebens, J Chung, GT Shan, V Radojcic, ... The Journal of clinical investigation 123 (4), 1590-1604, 2013 | 179 | 2013 |
| Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease Y Zhang, AR Sandy, J Wang, V Radojcic, GT Shan, IT Tran, A Friedman, ... Blood, The Journal of the American Society of Hematology 117 (1), 299-308, 2011 | 142 | 2011 |
| Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination V Radojcic, KB Bezak, M Skarica, MA Pletneva, K Yoshimura, ... Cancer immunology, immunotherapy 59, 137-148, 2010 | 134 | 2010 |
| STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model V Radojcic, MA Pletneva, HR Yen, S Ivcevic, A Panoskaltsis-Mortari, ... The journal of immunology 184 (2), 764-774, 2010 | 110 | 2010 |
| National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-Host disease: IV. the 2020 highly morbid forms report D Wolff, V Radojcic, R Lafyatis, R Cinar, RK Rosenstein, EW Cowen, ... Transplantation and cellular therapy 27 (10), 817-835, 2021 | 86 | 2021 |
| Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands J Chung, CL Ebens, E Perkey, V Radojcic, U Koch, L Scarpellino, A Tong, ... The Journal of clinical investigation 127 (4), 1574-1588, 2017 | 83 | 2017 |
| Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis N Durakovic, V Radojcic, A Boban, M Mrsic, D Sertic, R Serventi-Seiwerth, ... Internal medicine 50 (9), 1009-1013, 2011 | 60 | 2011 |
| Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning SR McCurdy, V Radojcic, HL Tsai, A Vulic, E Thompson, S Ivcevic, ... Blood, The Journal of the American Society of Hematology 139 (4), 608-623, 2022 | 57 | 2022 |
| Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusions N Durakovic, KB Bezak, M Skarica, V Radojcic, EJ Fuchs, GF Murphy, ... The Journal of Immunology 177 (7), 4414-4425, 2006 | 50 | 2006 |
| Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disorders MY Chiang, V Radojcic, I Maillard Current opinion in hematology 23 (4), 362-370, 2016 | 42 | 2016 |
| Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse N Durakovic, V Radojcic, M Skarica, KB Bezak, JD Powell, EJ Fuchs, ... Blood 109 (10), 4564-4574, 2007 | 39 | 2007 |
| Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia S Rutella, J Vadakekolathu, F Mazziotta, S Reeder, TO Yau, ... The Journal of Clinical Investigation 132 (21), 2022 | 37 | 2022 |
| Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice V Radojcic, K Paz, J Chung, J Du, ET Perkey, R Flynn, S Ivcevic, M Zaiken, ... Blood, The Journal of the American Society of Hematology 132 (20), 2188-2200, 2018 | 36 | 2018 |
| Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantation S Wood, J Feng, J Chung, V Radojcic, AR Sandy-Sloat, A Friedman, ... The Journal of Immunology 194 (6), 2899-2908, 2015 | 36 | 2015 |
| IFN-producing killer dendritic cells are antigen-presenting cells endowed with T-cell cross-priming capacity M Pletneva, H Fan, JJ Park, V Radojcic, C Jie, Y Yu, C Chan, A Redwood, ... Cancer research 69 (16), 6607-6614, 2009 | 36 | 2009 |
| BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation W Jia, JC Poe, H Su, S Anand, GK Matsushima, JC Rathmell, I Maillard, ... Blood, The Journal of the American Society of Hematology 137 (18), 2544-2557, 2021 | 30 | 2021 |
| Naive and memory B cells respond differentially to T‐dependent signaling but display an equal potential for differentiation toward the centroblast‐restricted CD77 … A Gagro, KM Toellner, G Grafton, D Servis, S Branica, V Radojčić, E Kosor, ... European journal of immunology 33 (7), 1889-1898, 2003 | 25 | 2003 |
| Axatilimab for chronic graft-versus-host disease after failure of at least two prior systemic therapies: results of a phase I/II study CL Kitko, M Arora, Z DeFilipp, MA Zaid, A Di Stasi, V Radojcic, CB Betts, ... Journal of Clinical Oncology 41 (10), 1864-1875, 2023 | 20 | 2023 |
| The role of extracorporeal photopheresis in chronic graft-versus-host disease V Radojcic, MA Pletneva, DR Couriel Transfusion and Apheresis Science 52 (2), 157-161, 2015 | 17 | 2015 |
| Mechanism of action of posttransplantation cyclophosphamide: more than meets the eye V Radojcic, L Luznik The Journal of clinical investigation 129 (6), 2189-2191, 2019 | 16 | 2019 |
Bruce Blazar在 umn.edu 的电子邮件经过验证
